This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Hydroxychloroquine for COVID-19

Off-label COVID-19 treatment approach involving hydroxychloroquine, often discussed in early COVID-19 treatment protocols. Hydroxychloroquine was widely discussed early in the COVID-19 pandemic as a possible outpatient or early-treatment agent, including in medical-freedom and early-treatment advocacy circles. Peter A. Mc Cullough has been associated with the broader early-treatment movement that included hydroxychloroquine and other repurposed medications.

Articles

Media Matters Criticism of Tom Paladino Scalar Light Claims

Eric Hananoki | Media Matters for America | Both

Criticism of Scalar Light COVID/cancer claims

Media Matters criticized Tom Paladino and Scalar Light, alleging claims about preventing health problems including cancer and treating serious infections through client-submitted photographs and light energy.

Coronavirus Disease 2019 (COVID-19) Vaccine Safety

Centers for Disease Control and Prevention | Public / Patient

COVID-19 vaccine safety monitoring

CDC overview of COVID-19 vaccine safety monitoring and rare adverse events including myocarditis, pericarditis, and thrombosis with thrombocytopenia syndrome after J&J/Janssen vaccination.
All Protocols